Cash position at 31 December 2020: â¬10.6 million Cash runway to end of 2021 PRIMAvera European pivotal study of Prima System initiated in Q4 2020 Paris, 19 February 2021 â 7.00 a.m. CET - Pixium Vision (FR0011950641 - PIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, announces its financial results for 2020. The 2020 financial statements were approved by Pixium Vision s Board of Directors at its meeting on 18 February 2021.
Lloyd Diamond, CEO of Pixium Vision commented We continued in 2020 to deliver on our plan of transitioning Pixium Vision from a research project to a commercially oriented company. We progressed our innovative Prima System to the last step of clinical development in Europe by initiating the PRIMAvera pivotal study and strengthened our presence in the US in anticipation of increasing clinical development in this key market. We are well positio